Correlation Between Tonix Pharmaceuticals and Moleculin Biotech

Can any of the company-specific risk be diversified away by investing in both Tonix Pharmaceuticals and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tonix Pharmaceuticals and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tonix Pharmaceuticals Holding and Moleculin Biotech, you can compare the effects of market volatilities on Tonix Pharmaceuticals and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tonix Pharmaceuticals with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tonix Pharmaceuticals and Moleculin Biotech.

Diversification Opportunities for Tonix Pharmaceuticals and Moleculin Biotech

0.21

Correlation Coefficient

Tonix Pharmaceuticals  Moleculin Biotech

Modest diversification

The 3 months correlation between Tonix and Moleculin is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Tonix Pharmaceuticals Holding and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and Tonix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tonix Pharmaceuticals Holding are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of Tonix Pharmaceuticals i.e., Tonix Pharmaceuticals and Moleculin Biotech go up and down completely randomly.

Pair Corralation between Tonix Pharmaceuticals and Moleculin Biotech

Given the investment horizon of 90 days Tonix Pharmaceuticals Holding is expected to under-perform the Moleculin Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Tonix Pharmaceuticals Holding is 2.35 times less risky than Moleculin Biotech. The stock trades about -0.08 of its potential returns per unit of risk. The Moleculin Biotech is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  179.00  in Moleculin Biotech on December 5, 2024 and sell it today you would lose (61.00) from holding Moleculin Biotech or give up 34.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Tonix Pharmaceuticals Holding  vs.  Moleculin Biotech

Tonix Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Tonix Pharmaceuticals Holding are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Tonix Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Moleculin Biotech

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Moleculin Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Moleculin Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Tonix Pharmaceuticals and Moleculin Biotech

The main advantage of trading using opposite Tonix Pharmaceuticals and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tonix Pharmaceuticals position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.

The idea behind Tonix Pharmaceuticals Holding and Moleculin Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.